Development and Evaluation of an Intelligent Parent-Infant Connection-Based Intervention to Strengthen Family Resilience in Preterm Infant Care

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorNational Defense Medical Center, Taiwan

About this trial

This study aims to develop, optimize, and evaluate the effectiveness of a family resilience intervention centered on intelligent parent-infant connection for parents of preterm infants. Using a longitudinal randomized controlled trial design, it examines the intervention's impact on parental psychosocial health, parenting efficacy, family resilience, and parent-infant interaction from NICU hospitalization to six months post-discharge.

Eligibility criteria

Qualifiers

The infant is born prematurely with a gestational age of less than 37 weeks.

At least one parent of the premature infant is aged 18 years or older and can communicate in Mandarin or Taiwanese.

The parent(s) have provided informed consent to participate in the study.

The parent(s) are able to comply with the data collection procedures (participation of both parents is encouraged but not required).

Disqualifiers

The premature infant has major congenital anomalies or is assessed by clinicians as unlikely to survive.

The parent(s) are unable to use a smartphone or internet-connected device due to technical, cognitive, or other limitations.

The parent(s) have a known history of severe psychiatric disorders, intellectual disabilities, or substance abuse, and are assessed by the research team as being unable to comply with the study procedures or intervention requirements.

Trial design

Treatments tested in this trial

  • Intelligent Intervention to enhance Parent-Infant Connection and Family Resilience
  • Routine Care

Treatment groups

300 Participants
are divided into 2 treatment groups

Locations

This trial has no locations